Stryker Neurovascular (Kalamazoo, Michigan) reported that its Trevo Pro Retriever has been granted 510(k) market clearance by the FDA. The Trevo Pro Retriever is the next generation in clot removal technology from Stryker, using its Stentriever technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke. Read More
